Tag: Colorectal cancer

The Cologuard test has a false-positive rate of about 13% [1.6.2]. While the test does not require medication changes, understanding what medications can cause a false positive Cologuard test is crucial for interpreting results, as some drugs can cause non-cancerous gastrointestinal bleeding [1.4.3, 1.5.7].

In clinical trials, the most common adverse reactions (≥10%) for patients taking Lonsurf included anemia, neutropenia, fatigue, nausea, and diarrhea. Understanding **what are the common side effects of Lonsurf** is key for patients and caregivers managing this cancer treatment.

The FDA approved the first generic version of capecitabine in 2013, making this oral chemotherapy more accessible to patients with certain cancers. Knowing what is the generic for capecitabine can help individuals understand their medication options and potential cost savings during cancer treatment.

Originally approved by the FDA in 2012 for metastatic colorectal cancer, a key question for patients and caregivers is, What is another name for Regorafenib? The answer is its brand name, Stivarga, an oral multi-kinase inhibitor developed by Bayer.

Vectibix is the brand name for the generic drug panitumumab, a targeted monoclonal antibody therapy. While the generic name is known, Vectibix does not have a traditional generic equivalent on the market, as it is a complex biologic medication. The availability of biosimilar versions depends on patent expirations and regulatory approval.

In 2006, the U.S. Food and Drug Administration granted approval to panitumumab (brand name Vectibix) for the treatment of certain patients with metastatic colorectal cancer. The current owner of panitumumab is the global biotechnology company Amgen Inc., following a key acquisition that secured its intellectual property and commercial rights.

Leucovorin, a medication also known as folinic acid, is a crucial component in certain cancer treatments and can act as an antidote to the side effects of specific chemotherapies. A primary purpose of leucovorin is to protect healthy cells from harm during high-dose chemotherapy regimens.

Approximately 80% of cancer treatments involve a combination of therapies. Versavo 400, a biosimilar of bevacizumab, is a targeted anti-cancer drug used in combination with other chemotherapy drugs for treating several types of advanced cancers.

First developed as an antitumor agent, the drug trifluridine is now most commonly known in its ophthalmic form (Viroptic) for treating viral eye infections, while a combination oral tablet (Lonsurf) is used to fight certain types of cancer. This unique versatility means that what is the drug trifluridine used for depends entirely on its formulation.

Xeloda, a brand name for the chemotherapy drug capecitabine, is a crucial oral medication utilized in the treatment of several types of cancer. Unlike many other chemotherapy drugs administered intravenously, Xeloda is a pill, making it a more convenient option for many patients. The primary question, "what is xeloda used for?", centers on its effectiveness against fast-growing cancer cells in breast, colon, and other gastrointestinal cancers.